Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.

Of the known biochemical actions of caffeine, only inhibition of adenosine receptors occurs at concentrations achieved during normal human consumption of the drug. Under normal physiological conditions, adenosine is present in sufficient concentrations to activate A1 and A2a receptors. Via actions on A1 receptors, adenosine decreases neuronal firing and the release of neurotransmitters. The exact mechanisms are not known, but several possibilities are discussed. Via actions on A2a receptors, adenosine--and hence caffeine--can influence dopaminergic neurotransmission. Caffeine can induce rapid changes in gene expression and, somewhat later, marked adaptive changes. These include antiepileptic and neuroprotective changes. Thus, caffeine has a number of central effects directly or indirectly related to adenosine receptors. Some of these are potentially useful, and drug development based on the actions of caffeine should be interesting.

[1]  M. Hadfield,et al.  Caffeine and regional brain monoamine utilization in mice. , 1989, Life sciences.

[2]  K. Ikeda,et al.  Calcium-induced translocation of synaptic vesicles to the active site , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  T. Dunwiddie The physiological role of adenosine in the central nervous system. , 1985, International review of neurobiology.

[4]  Activation of adenylate cyclase from rat striatum and tuberculum olfactorium by adenosine. , 1977 .

[5]  E. M. Silinsky On the mechanism by which adenosine receptor activation inhibits the release of acetylcholine from motor nerve endings. , 1984, The Journal of physiology.

[6]  B. Fredholm,et al.  Are methylxanthine effects due to antagonism of endogenous adenosine , 1979 .

[7]  B. Fredholm,et al.  Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat , 1994, Neuroscience.

[8]  B. Fredholm,et al.  Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment , 1989, Neuroscience Letters.

[9]  Roland R. Griffiths,et al.  Reinforcing effects of caffeine in humans , 1988, Pharmacology Biochemistry and Behavior.

[10]  K. Fuxe,et al.  Adenosine-dopamine interactions in the brain , 1992, Neuroscience.

[11]  Roland R. Griffiths,et al.  Reinforcing properties of caffeine: Studies in humans and laboratory animals , 1988, Pharmacology Biochemistry and Behavior.

[12]  Mark K. Bennett,et al.  A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion , 1993, Cell.

[13]  K. Jacobson,et al.  Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory. , 1993, European journal of pharmacology.

[14]  C F Stevens,et al.  Increased transmitter release at excitatory synapses produced by direct activation of adenylate cyclase in rat hippocampal slices , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  B. Fredholm,et al.  Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion , 1993, Neurochemistry International.

[16]  E. Newsholme,et al.  The control of the metabolism and the hormonal role of adenosine. , 1978, Essays in biochemistry.

[17]  R. McCarley,et al.  Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. , 1994, Science.

[18]  B. Fredholm,et al.  The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum. , 1993, European journal of pharmacology.

[19]  S. Grant,et al.  Methylxanthine activation of noradrenergic unit activity and reversal by clonidine. , 1982, European journal of pharmacology.

[20]  B. Fredholm,et al.  Effect of an intracellular calcium chelator on the regulation of electrically evoked [3H]‐noradrenaline release from rat hippocampal slices , 1993, British journal of pharmacology.

[21]  B. Fredholm,et al.  How does adenosine inhibit transmitter release? , 1988, Trends in pharmacological sciences.

[22]  Richard Robitaille,et al.  Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release , 1993, Neuron.

[23]  B. Fredholm,et al.  Propentofylline and Other Adenosine Transport Inhibitors Increase the Efflux of Adenosine Following Electrical or Metabolic Stimulation of Rat Hippocampal Slices , 1994, Journal of neurochemistry.

[24]  B. Fredholm,et al.  Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia , 1990, British journal of pharmacology.

[25]  T. Dunwiddie Endogenously Released Adenosine Regulates Excitability in the In Vitro Hippocampus , 1980, Epilepsia.

[26]  U. Ungerstedt,et al.  Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus , 1990, Brain Research.

[27]  F Benfenati,et al.  Synaptic vesicle phosphoproteins and regulation of synaptic function. , 1993, Science.

[28]  T. Dunwiddie,et al.  Inhibition of Purkinje cell firing by systemic administration of phenylisopropyl adenosine: effect of central noradrenaline depletion by DSP4. , 1985, Life sciences.

[29]  K. Jacobson,et al.  Locomotor activity in mice during chronic treatment with caffeine and withdrawal , 1993, Pharmacology Biochemistry and Behavior.

[30]  K. Jacobson,et al.  Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. , 1993, European journal of pharmacology.

[31]  R. Miller,et al.  Analysis of adenosine actions on Ca2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurones. , 1991, The Journal of physiology.

[32]  R. Tsien,et al.  Distinctive biophysical and pharmacological properties of class A (BI) calcium channel α 1 subunits , 1993, Neuron.

[33]  K. Minneman,et al.  Role of adenosine receptors in caffeine tolerance. , 1991, The Journal of pharmacology and experimental therapeutics.

[34]  J. Phillis,et al.  Effects of adenosine analogs on rat cerebral cortical neurons. , 1976, Life sciences.

[35]  B B Fredholm,et al.  Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Momiyama,et al.  Different types of calcium channels mediate central synaptic transmission , 1993, Nature.

[37]  R Workman,et al.  Tolerance to the humoral and hemodynamic effects of caffeine in man. , 1981, The Journal of clinical investigation.

[38]  Y. Chern,et al.  Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. , 1993, Molecular pharmacology.

[39]  Presynaptic regulation of hippocampal acetylcholine release is unaffected by calcium channel blockers and intracellular calcium chelation. , 1993, Acta physiologica Scandinavica.

[40]  Stephen G. Holtzman,et al.  Tolerance to behavioral effects of caffeine in rats , 1988, Pharmacology Biochemistry and Behavior.

[41]  M. Adams,et al.  Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neurons , 1993, Neuron.

[42]  B. Fredholm,et al.  Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. , 1993, The Journal of pharmacology and experimental therapeutics.

[43]  K. Fuxe,et al.  Effect of some phosphodiesterase inhibitors on central dopamine mechanisms. , 1976, European journal of pharmacology.

[44]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[45]  B. Gähwiler,et al.  Comparison of the actions of adenosine at pre‐ and postsynaptic receptors in the rat hippocampus in vitro. , 1992, The Journal of physiology.

[46]  D. Hommer,et al.  Preferential effects of caffeine on limbic and cortical dopamine systems , 1988, Biological Psychiatry.

[47]  Thomas C. Südhof,et al.  The role of Rab3A in neurotransmitter release , 1994, Nature.

[48]  B. Fredholm,et al.  Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number , 1993, Brain Research.

[49]  B. Fredholm,et al.  Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. , 1991, Acta physiologica Scandinavica.

[50]  G. Augustine,et al.  Synaptotagmin and neurotransmitter release , 1993, Cell.

[51]  A. Tsugita,et al.  A complex of rab3A, SNAP‐25, VAMP/synaptobrevin‐2 and syntaxins in brain presynaptic terminals , 1993, FEBS letters.

[52]  U. Ungerstedt,et al.  Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre , 1982, Neuroscience Letters.

[53]  Richard J. Miller,et al.  Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses , 1992, Neuron.

[54]  B. Fredholm,et al.  Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices , 1995, Neurochemistry International.

[55]  T. Dunwiddie,et al.  In vivo pertussis toxin treatment attenuates some, but not all, adenosine A1 effects in slices of the rat hippocampus. , 1989, European journal of pharmacology.

[56]  B B Fredholm,et al.  Adenosine actions and adenosine receptors after 1 week treatment with caffeine. , 1982, Acta physiologica Scandinavica.

[57]  B. Fredholm,et al.  Metabolism of adenosine and 2'-deoxy-adenosine by fetal mouse calvaria in culture. , 1982, Medical biology.

[58]  B B Fredholm,et al.  Modulation of neurotransmission by purine nucleotides and nucleosides. , 1980, Biochemical pharmacology.

[59]  G. Augustine,et al.  A functional role for GTP-binding proteins in synaptic vesicle cycling. , 1993, Science.